Effects of antibodies to phosphorylated and non-phosphorylated tau on in vitro tau phosphorylation at Serine-199: Preliminary report.
ScienceDirect; doi:10.1016/j.exger.2015.04.010.
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
The Journal of the Alzheimer’s Association; doi.org/10.1016/j.jalz.2015.05.012.
Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
PLOS One; DOI: 10.1371/journal.pone.0125614
Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent.
ScienceDirect; doi:10.1016/j.neurobiolaging.2014.12.004.
Human secreted tau increases amyloid-beta production
ScienceDirect; doi:10.1016/j.neurobiolaging.2014.09.007.
Anti-tau antibody reduces insoluble tau and decreases brain atrophy
Annals of Clinical and Translational Neurology; DOI: 10.1002/acn3.176.
Effects of Tau Domain-Specific Antibodies and Intravenous Immunoglobulin on Tau Aggregation and Aggregate Degradation.
ACS Publications; DOI: 10.1021/bi501272x.
On-chip detection of wild 3R, 4R and mutant 4R tau through kinesin-microtubule binding
IEEE Xplore; doi: 10.1109/MEMSYS.2015.7050988
Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent
Neurobiology of Aging; DOI: http://dx.doi.org/10.1016/j.neurobiolaging.2014.12.004.
Tau Monoclonal Antibody Generation based on Humanized Yeast Models: Impact on Tau Oligomerization and Diagnostics.
The Journal of Biological Chemistry; doi: 10.1074/jbc.M114.627919.